News

Fierce Biotech2d
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi’s 11 months watching over Vigil Neuroscience have led to a $470 million buyout. | Sanofi’s 11 months watching over ...
NJBIZ16h
Sanofi’s $130M Morristown flagship puts people first
Sanofi relocated 2,000 employees to a new $130M Morristown flagship office at M Station West in May, leaving Bridgewater.
PharmTech19h
Sanofi to Acquire Vigil Neuroscience to Expand Neurodegenerative Disease Pipeline
Sanofi is acquiring Vigil Neuroscience, a biotech firm focused on novel neurodegenerative disease therapies, to boost its ...
Medical Dialogues57m
Sanofi Gets CDSCO Panel Nod to Update Aldurazyme Prescribing Information
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to ...
New Jersey Business Magazine23h
Sanofi Opens $130M Offices in Morristown
Global healthcare company Sanofi yesterday formally opened its new flagship US offices at M Station West in Morristown.
Sanofi Redefines R&D strategy with AI: Vanguards of Health Care
Houman Ashrafian, Head of R&D at Sanofi. In this episode, Ashrafian joins Bloomberg Intelligence analyst Sam Fazeli to unpack how AI-powered portfolio construction, franchise-based innovation and a ...
Explore more
BioSpace1d
GSK Wins COPD Expansion for Nucala After FDA Delay
The approval tees GSK up to challenge Sanofi and Regeneron, which in September 2024 won the first biologic approval for COPD ...